Expression of dynein, cytoplasmic 2, heavy chain 1 (DHC2) associated with glioblastoma cell resistance to temozolomide

Temozolomide (TMZ) is the main chemotherapeutic drug utilized for the treatment of glioblastoma multiforme (GMB), however, drug resistance often leads to tumor recurrence and poor outcomes. GMB cell lines were treated with TMZ for up to two weeks and then subjected to proteomics analysis to identify...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Rep
Main Authors: Wang, Hai, Feng, Wenfeng, Lu, Yuntao, Li, Hezhen, Xiang, Wei, Chen, Ziyang, He, Minyi, Zhao, Liang, Sun, Xuegang, Lei, Bingxi, Qi, Songtao, Liu, Yawei
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4931463/
https://ncbi.nlm.nih.gov/pubmed/27375225
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep28948
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados